Investor Presentation

Date: October 22, 2026 To, To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/1, G-Block Dalal Street Mumbai - 400 001 Bandra-Kurla Complex Scrip Code:544282 Bandra (E), Mumbai - 400 051 Symbol: SAGILITY Dear Sir/Ma’am, Subject: Submission of Investor Presentation to be made to investors on October 22, 2026, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In continuation of our letter dated October 14, 2026, please find enclosed the investor presentation on the financial results of Sagility Limited for the quarter and half-year ended September 30, 2026. The presentation will be made to investors during the meeting scheduled for today, Thursday, October 22, 2026, at 7:30 p.m. (IST). The details are also being made available on the Company’s website https://sagility.com/ This is for your kind information and record. Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No: A16008 Encl: a/a Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru – 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Investor Deck – Q2 FY27 Oct 22, 2026 Safe Harbor Certain statements in this release concerning Sagility’s future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. Sagility does not undertake to update any such statement that may have been made from time to time by or on behalf of the company. Performance Highlights Q2 FY27 Business Insights H1 FY27 ▶ 11.9% Y-o-Y Constant currency organic growth in Q2 FY27, driven by expansion within national payers and mid market Adjusted Adjusted clients Adjusted Adjusted Revenue Revenue EBITDA PAT EBITDA PAT ▶ Won $40.2 M of ACV in Q2 FY27, from 31 existing clients and ₹ 20,321 ₹ 5,353 ₹ 3,254 1 new logo. Increasing traction seen in larger deals, supported ₹ 39,956 ₹ 10,069 ₹ 5,951 Million Million Million by cross-sell and transformation-led opportunities Million Million Million US$212.6M US $56.0M US$34.0M US$420.4M US $105.9M US$62.6M ▶ Growing AI momentum with new SOW wins, production YoY growth % Margin % Margin % deployments driving client efficiencies, and AI-led GTM YoY growth % Margin % Margin % 22.5% 26.3% 16.0% transformation enabling faster solutioning 25.0% 25.2% 14.9% 12.2% in CC ▶ Acquired Chirok Health LLC to accelerate Provider segment 13.7% in CC growth. The acquisition adds specialized CDI and coding YoY growth % YoY YoY YoY growth % YoY YoY (Excl. CareSeed) growth % growth % capabilities, extending Sagility’s end-to-end RCM offering and (Excl. CareSeed) growth % growth % 22.2% 23.0% 8.1% unlocking new growth opportunities. 24.7% 25.2% 18.9% 11.9% in CC Interim Dividend ₹0.15 per share 13.4% in CC Rewards & Recognitions Sagility India ranked 57 in 100 Best Winner of Bronze Stevie® Leader in Avasant’s Healthcare Large Workplaces in Asia 2026 by Great Award in the AI Adoption Place to Work®. with Headcount Growth Payer Business Process Transformation 2026 RadarView Recognized amongst Top 10 India’s Best Received the Workplaces for Women 2026 Sagility’s SmarTec Nurse Assist Voice of the Sagility won the Golden solution won 2026 Stratus Awards Customer Honor Sagility India earns Great Place To Peacock Award for ESG for Cloud Computing by Business – HLS Services Work® Certification for the second Intelligence Group in SaaS category Specialist consecutive year KPIs Q2 FY27 Q1 FY27 Q2 FY26 YoY% H1 FY27 H1 FY26 YoY% Revenue from Operation (in ₹ M) 20,321 19,635 16,585 22.5% 39,956 31,974 25.0% Steady state Revenue 20,321 19,635 16,585 22.5% 39,956 31,974 25.0% Seasonal Revenue (Open Enrollment/AEP) - - - - - - - Revenue by Vertical Split By Payer 89.9% 89.6% 88.5% 89.7% 88.4% By Provider 10.1% 10.4% 11.5% 10.3% 11.6% Growth in revenue from operation (%) 22.5% 27.6% 25.2% 25.0% 25.5% Adjusted EBITDA* (in ₹ M) 5,353 4,716 4,352 23.0% 10,069 8,039 25.2% Adjusted EBITDA % 26.3% 24.0% 26.2% 25.2% 25.1% Adjusted PAT** (in ₹ M) 3,254 2,697 3,010 8.1% 5,951 5,007 18.9% Adjusted PAT % 16.0% 13.7% 18.1% 14.9% 15.7% Total Number of Employees at the end of period 51,486 47,307 44,185 16.5% 51,486 44,185 16.5% Voluntary attrition rate^ (%) 25.7% 28.6% 26.3% 26.6% 26.3% Note: *Adjusted EBITDA represents EBITDA adjusted for earnouts payable under acquisition agreements (DCI, BirchAI , BroadPath & CareSeed), share-based payment awards and excludes other income (including forex gain/loss). **Adjusted PAT reflects EBITDA adjustments excluding other income and FX and adjustments for amortization of intangible assets arising from the carve-out of the healthcare business from HGS, as well as the statutory impact of increase in Minimum wages in Karnataka & Telangana, net of tax ^Voluntary attrition is calculated for employees with tenure exceeding 90 days and presented on an annualized basis, derived from voluntary exits during the respective quarter Annual KPIs H1 FY27 FY26 FY25 FY24 FY23 Numbers of Client group Active 105 82 75 44 35 Number of new client addition (Gross) 28** 17 38 13 7 Delivery Sites Number of delivery sites 28 31 33 30 27 New site addition (Gross) - 4 10 4 2 TTM Sep26 FY26 FY25 FY24 FY23 Client groups contribution to revenues* Top 3 Client % 60.1% 59.9% 66.2% 68.3% 72.4% Top 5 Client % 70.3% 70.4% 77.9% 79.2% 80.6% Top 10 Client % 84.4% 83.9% 90.5% 91.4% 90.7% Number of Million-dollar client groups Number of clients contributing more than US$ 20M 10 9 7 5 4 Number of clients contributing to US$ 5M - US$ 20M 8 7 6 7 7 Number of clients contributing to US$ 1M - US$ 5M 22 21 12 12 12 Number of clients contributing less than US$ 1M 65 45 50 20 12 *Client groups comprise client entities together with their affiliates. **30 clients added via CareSeed acquisition – 26 new client groups, 2 common client groups, 2 affiliates of existing client groups Comprehensive end-to-end Provider RCM solution Chirok strengthens Sagility’s provider footprint Founded in 2020 and headquartered in Nashville, Chirok Health is a specialized provider of Clinical Documentation Improvement (CDI) solutions. The company complements its core CDI offerings with adjacent solutions, including medical coding, RAC, and HEDIS/Stars quality services. US$20 M US$13 M 35.8% 12+ 115%+ 750+ n t Upfront payment Additionally, contingent consideration up to TTM Sep2026 TTM Sep 2026 Provider Clients (including Net revenue l Employees a US$12.35 M payable subject to achievement of revenue Adjusted EBITDA margin large hospital systems) retention¹ V specified performance milestones What Chirok adds to Sagility Mid-revenue CHEMP Provider Specialist Cycle expertise Workflow platform relationships talent Prospective, concurrent Health systems 700+operations staff & retrospective CDI Physician groups Review Validate Audit Coding, QA & billing Risk-bearing providers India & US delivery Coding & quality audits Provider queries Unlocks synergies to broaden Sagility’s provider offering and deliver greater client value 1percentage of recurring revenue retained from existing customer base over a set period, including upgrades/expansions while subtracting downgrades/churn. Chirok bridges the CDI and coding gap, enabling Sagility to offer more comprehensive end-to-end provider revenue solutions Sagility Chirok core Combined scope Sagility Sagility Patient Clinical Documentation Billing Clinical denials A/R & access & coding & claims & appeals collections Growth opportunities Deepen provider relationships Support [Showing first 8,000 characters — download PDF for full document]